Shan-Bu Xie

发表

Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity

B. Henriques-Normark, K. Pütsep, K. Subramanian, 2016, PloS one.

A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia

Weifang Zhang, H. Zeng, Shan-Bu Xie, 2021, BioMed research international.

Design, synthesis, and biological evaluations of substituted pyrazoles as pyrrolomycin analogues against staphylococcal biofilm.

L. Lan, Xiaofei Zhang, Chunhao Yang, 2022, European journal of medicinal chemistry.

Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7

Sihan Wu, Guangmei Yan, Shan-Bu Xie, 2013, Oncology letters.

An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension

Weifang Zhang, Shan-Bu Xie, Fei Xu, 2021, BioMed research international.

SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma

Weifang Zhang, Shan-Bu Xie, Xinyi Zhang, 2019, Oncology letters.

The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis

Weifang Zhang, Shan-Bu Xie, Jingjing Chen, 2021, European Journal of Clinical Pharmacology.

Discovery of Novel N-Heterocyclic-Fused Deoxypodophyllotoxin Analogues as Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer Treatment.

Yuan-zheng Xia, Yong Yin, Shan-Bu Xie, 2022, Journal of medicinal chemistry.

Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells.

Shukun Yao, Shan-Bu Xie, Xing-Xing He, 2015, International journal of oncology.

Synthesis of Cyclodextrin-based MOFs incorporating amino acid chiral ligands for chiral separation of naproxen enantiomers

Ning Liang, Shan-Bu Xie, Yiqun Li, 2023, Microchemical Journal.